Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
- Conditions
- Pain
- Interventions
- Drug: Placebo
- Registration Number
- NCT01866917
- Lead Sponsor
- Montefiore Medical Center
- Brief Summary
Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 35
- BMI greater than or equal to 30, women undergoing laparoscopic or robotic in-patient procedures
- Conversions, non-obese women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Saline Placebo Patients will receive Normal saline 20cc injectate from a study labeled syringe TAP Ropivacaine 0.5% 20cc injectate bilaterally Patients will receive Ropivicaine 0.5% 20cc injectate from a study labeled syringe
- Primary Outcome Measures
Name Time Method Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable) 0, 1, and 2 hours Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable) 4hrs, 8hrs, 12hrs, and 24hrs. Pain assessments by verbal numerical pain score (NPS) at 4, 8, 12 and 24 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Moses Medical Center
🇺🇸Bronx, New York, United States